Subscribe
trade-secrets-istock-515925626-guvendemir
guvendemir / iStockphoto.com
30 January 2019Americas

Chinese national jailed for stealing medical devices tech

A US district court has sentenced a Chinese national to 27 months in federal prison for the theft of trade secrets from two American medical device manufacturers.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Former Genentech employees charged with trade secrets theft
1 November 2018   Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Americas
Former Genentech employees charged with trade secrets theft
1 November 2018   Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.

More on this story

Americas
Former Genentech employees charged with trade secrets theft
1 November 2018   Alex Tse, US attorney for the Northern District of California, has charged three former Genentech employees with trade secrets theft.

More features

Teva fights for re-listing of inhaler patents at US appeals court
CRISPR patents revoked following Nobel Prize winners’ withdrawal
White & Case hires experienced litigator from A&O Shearman
President Trump 2.0: Five major areas to watch
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?